Cipla shares drop 3.7% after Eli Lilly deal, but analysts see strong growth in India's obesity market—learn more about the ...
Eli Lilly's new U.S. facility will be just the first of four that it plans to build in the country. The company expects to ...
Asianet Newsable on MSN
Cipla Shares Fall To Biggest Intra-day Lows In Six Months Despite Eli Lilly Deal For Diabetes Drug
Cipla-Eli Lilly partner to distribute Tirzepatide under the Yurpeak brand in India Tirzepatide is used to manage type 2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback